Faron Pharmaceuticals Oy (FARN) Insider Trading & Ownership GBX 219 +4.00 (+1.86%) As of 06/6/2025 11:17 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Faron Pharmaceuticals Oy (LON:FARN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.82%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)£1.86M Get FARN Insider Trade Alerts Want to know when executives and insiders are buying or selling Faron Pharmaceuticals Oy stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FARN Insider Buying and Selling by Quarter Faron Pharmaceuticals Oy Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/3/2025Markku JalkanenInsiderSell600,000GBX 310£1,860,000 (Data available from 1/1/2013 forward) FARN Insider Trading Activity - Frequently Asked Questions Who is on Faron Pharmaceuticals Oy's Insider Roster? The list of insiders at Faron Pharmaceuticals Oy includes John Poulos, and Markku Jalkanen. Learn more on insiders at FARN. What percentage of Faron Pharmaceuticals Oy stock is owned by insiders? 31.82% of Faron Pharmaceuticals Oy stock is owned by insiders. Learn more on FARN's insider holdings. Which Faron Pharmaceuticals Oy insiders have been selling company stock? The following insiders have sold FARN shares in the last 24 months: John Poulos (£37,750), and Markku Jalkanen (£1,860,000). How much insider selling is happening at Faron Pharmaceuticals Oy? Insiders have sold a total of 610,000 Faron Pharmaceuticals Oy shares in the last 24 months for a total of £1,897,750 sold. Faron Pharmaceuticals Oy Key ExecutivesDr. Juho Markku Jalkanen M.D. (Age 46)MSc, Ph.D., Founder, CEO & Director Compensation: $431.48kMr. Yrjö Erik Kristian Wichmann M.Sc (Econ.) (Age 66)M.Sc., Interim Chief Financial Officer Compensation: $383.72kDr. Maija Hollmen Ph.D.Chief Scientific OfficerMr. Vesa Karvonen L.L.M. (Age 52)General Counsel Ms. Jennifer Smith-ParkerHead of CommunicationsDr. Juhana HeinonenChief Commercial OfficerDr. Petri Bono M.D. (Age 54)Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ONT Insider Transactions OXB Insider Transactions BVXP Insider Transactions 4BB Insider Transactions SAR Insider Transactions POLB Insider Transactions AREC Insider Transactions IXI Insider Transactions OBD Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play? This page (LON:FARN) was last updated on 6/7/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredPrepare now for May 31 eventPrepare now for June 30 event This man grew up in a trailer in New Mexico. Today, he's a multimillionaire t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
